세포 분석 시장 규모 : 제품 유형별, 세포 유형별, 최종사용자별, 지역별, 범위 및 예측

Cell Analysis Market Size And Forecast

Cell Analysis Market size was valued at USD 16.07 Billion in 2021 and is projected to reach USD 38.34 Billion by 2030 , growing at a CAGR of 10.15% from 2023 to 2030. The increasing government funding for cell-based research is the crucial aspect of the rise in the market revenue of Cell Analysis as well as the technological advancements in single-cell analysis products that will foster market growth. The Global Cell Analysis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cell Analysis Market Definition

Cell Analysis studies the genomics, metabolomics, transcriptomics, and proteomics of a living being at a single-cell level. The single-Cell Analysis is used in measuring, analyzing, and sequencing the human genome at a single-cell heterogeneity. Fluorescence-activated cell sorting isolates the selected single cells from complex samples. In clinical diagnostics, Cell Analysis is expected to standardize and automate workflows with valuable information for real-time monitoring of cancer and, eventually, new therapeutic strategies for the benefit of patients.

Cellular Analysis is vital in gene identification, protein identification, epigenomics, and other life science-related areas. Enhanced accuracy of cell imaging and analysis systems helps reduce the drug discovery process time and price. Today in most places, cells are analyzed in masses with thousands of cells per sample, and results are analyzed based on the average response of the cells. Hence to get practical and accurate Cell Analysis, it's essential to review how exactly individual cells respond.

Global Cell Analysis Market Overview

The Growth of the Cell Analysis Market is driven by the development of the healthcare industry and the rise in cancer incidence. Furthermore, the introduction of technologically advanced products and an increased number of hospitals, diagnostic laboratories, and others fuel the market growth. Moreover, increasing the adoption of Cell Analysis for diagnostic applications is a significant factor driving the development of the global Cell Analysis Market. Moreover, rising government investments and funding for cell-based research are other factors fueling the growth of the worldwide market.

Moreover, the increasing prevalence of infectious & chronic diseases and neurological disorders has positively anticipated propelling the growth of the global Cell Analysis Market. There are specific challenges faced that will hinder the overall market growth. Factors such as the high cost of instruments inhibit the market's growth. Also, the survival of small players and new entrants is the major challenge faced by the market. However, research and development in somatic cell research and cell sequencing may be expected to present lucrative business opportunities for major players within the global Cell Analysis Market.

Global Cell Analysis Market Segmentation Analysis

The Global Cell Analysis Market is segmented based on Product, Cell Type, End-User, And Geography.

Cell Analysis Market, By Product

• Consumables
• Instruments

Based on Product, the market is bifurcated into Consumables and Instruments. The consumables segment holds the largest market share during the forecast period. The factors that can be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are accelerating the demand for consumables segment.

Cell Analysis Market, By Cell Type

• Human Cells
• Animal Cells
• Microbial Cells

Based on Cell Type, the market is bifurcated into Human Cells, Animal Cells, and Microbial Cells. The human cells segment holds the largest market share. The factors that can be attributed to the high utilization of human cells in research laboratories and academic institutes are accelerating the demand.

Cell Analysis Market, By End-User

• Biotechnology Companies
• Hospitals
• Cell Banks
• Others

Based on End-User, the market is bifurcated into Biotechnology Companies, Hospitals, Cell Banks, and Others. The academic and research laboratories segment holds the largest market share during the forecast period. The factors that can be attributed to growth in funding for all times science research and therefore the increasing number of medical colleges and universities enhance the demand for academic and research laboratories segment.

Cell Analysis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of The World
• On the basis of Geography, the Global Cell Analysis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific holds the largest market share. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, growth in the outsourcing of drug discovery services to Asian CROs, strong governmental initiatives, and ongoing projects will boost the market in the APAC region.

Key Players

• The "Global Cell Analysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Becton, Dickinson and Company, Merck KGAA, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, Perkinelmer, Inc., Promega Corporation, and Tecan Group Ltd.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• Product Launches and Product Expansions
• In April 2018, BD (Becton, Dickinson and Business), a leading worldwide medical technology company, announced the launch of the BD FACSymphony(TM) S6 cell sorter, which will be on exhibit at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform takes advantage of the BD FACSymphony cell analyzer's high parameter capabilities, allowing researchers to sort cell populations to better understand cell phenotypes for immunology and multi-omics research.
• In May 2018, Beckman Coulter Life Sciences introduced the Kaluza C Flow Cytometry Analysis Software, a sophisticated data analysis system for clinical laboratories. The new program simplifies clinical QC reporting and addresses flow cytometry standardization difficulties.
• In September 2018, Leica Microsystems established the first Imaging Center in San Francisco. This facility will showcase the spectrum of technology in microscopes produced by Leica Microsystems for life sciences research.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CELL ANALYSIS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CELL ANALYSIS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Consumables
  • 5.2.1 Reagents
  • 5.2.2 Assay Kits
  • 5.2.2.1 Immuno assays
  • 5.2.2.2 Cell based assays
  • 5.2.3 Microplates
  • 5.2.4 Others
• 5.3 Instruments
  • 5.3.1 Microscopes
  • 5.3.2 Flow cytometry
  • 5.3.3 Spectrophotometers
  • 5.3.4 qPCR
  • 5.3.5 Cell Counters
  • 5.3.6 HCS Systems
  • 5.3.7 Cell Microarrays

6 GLOBAL CELL ANALYSIS MARKET, BY CELL TYPE

• 6.1 Overview
• 6.2 Human Cells
• 6.3 Animal Cells
• 6.4 Microbial Cells

7 GLOBAL CELL ANALYSIS MARKET, BY END-USER

• 7.1 Overview
• 7.2 Biotechnology Companies
• 7.3 Hospitals
• 7.4 Cell Banks
• 7.5 Others

8 GLOBAL CELL ANALYSIS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
• 8.6 Rest of the World
  • 8.6.1 Middle East and Africa

9 GLOBAL CELL ANALYSIS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Becton, Dickinson and Company
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Merck KGAA
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Thermo Fisher Scientific, Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Danaher Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 GE Healthcare
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Agilent Technologies, Inc.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Olympus Corporation
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Perkinelmer, Inc.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Promega Corporation
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Tecan Group Ltd.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research